Enoxaparin Sodium - NDC Database (Page 7)
63323-609 Jul 15, 2019
Enoxaparin Sodium 120 mg/.8ml Subcutaneous Injection by Fresenius Kabi USA, LLC
Enoxaparin Sodium 120 mg/.8ml Subcutaneous Injection by Fresenius Kabi USA, LLC
63323-655 May 01, 2019
Enoxaparin Sodium 120 mg/.8ml Subcutaneous Injection by Fresenius Kabi USA, LLC
Enoxaparin Sodium 120 mg/.8ml Subcutaneous Injection by Fresenius Kabi USA, LLC
68001-464 Oct 19, 2020
Enoxaparin Sodium 300 mg/3ml Intravenous; Subcutaneous Injection by Bluepoint Laboratories
Enoxaparin Sodium 300 mg/3ml Intravenous; Subcutaneous Injection by Bluepoint Laboratories
68001-641 May 01, 2025
Enoxaparin Sodium 300 mg/3ml Intravenous; Subcutaneous Injection by Bluepoint Laboratories
Enoxaparin Sodium 300 mg/3ml Intravenous; Subcutaneous Injection by Bluepoint Laboratories
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.